Johnson & Johnson MedTech‘s  Medical announced today that it initiated a study evaluating its Javelin coronary IVL catheter.

Cala today announced new results from multiple clinical studies further expanding the body of evidence for its TAPS therapy.

ICU Medical (Nasdaq: ICUI) today announced new regulatory milestones that open up a new category for its infusion systems.

Hologic (Nasdaq: HOLX) announced that it appointed Wayde McMillan to its board of directors, effective April 4, 2025.

The past week has been tough on the stocks of major medtech companies, which, like many, are figuring out how to manage the global trade war.

"The ongoing gutting of the FDA is likely to cause American deaths," said the CEO of one medical device developer.

Here are the biggest stories out of ACC 2025: Five-year data from the Medtronic Evolut Low Risk Trial confirmed that its ...

Cohen notably served as CEO and a member of the board at Axonics, a company he co-founded in 2013 and took public in 2018. A ...

FDA CDRH leaders and the entire FDA Office of Media Affairs were reportedly eliminated in the Trump Administration's mass ...

Anaconda Biomed announced the enrollment and treatment of the first U.S. patient in a clinical trial of its ANA Funnel ...

D-printed implant maker Restor3d announced today that it completed a funding round, bringing in proceeds totaling $38 million ...

Rhythm Technologies (Nasdaq: IRTC) announced results from two large, real-world analyses demonstrating the benefits of its ...